Protocol V503-001-04 "A randomized, international, double-blind (internally blinded), internally blinded, controlled by gardasil™, dose range determination on tolerability, immunogenicity, and efficacy of the multivalent l1 virus-like particle (VPL) vaccine against human papillomavirus (HPV) administered to women 16-26 years of age".

Project: Research project

Description

N/A
StatusFinished
Effective start/end date6/1/148/1/15